EUVIMEDEUVIMED entdecken
Crossref

Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery System

Trevor L Hoffman iD, Farah M Brasfield iD, Devansu Tewari, Jeffery D Greenberg, Hilary B Kershberg, John Goff iD, Reina Haque iD, Monica Alvarado

JCO Oncology Practice · 2025

DOI: 10.1200/op-24-00717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Trevor L Hoffman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Southern California Kaiser Permanente Medical Group, Pasadena, CA. Hauptthemen laut MEDLINE: Genetic Testing, Delivery of Health Care, Integrated, Germ-Line Mutation, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Demand for germline hereditary cancer genetic testing has increased because of reduced cost, gene discovery, expanding indications, and precision cancer therapies. The traditional model for germline testing, where a genetics provider performs all steps of the testing process (pretest counseling, test ordering, results disclosure, and post-test counseling), is no longer able to meet testing needs especially for patients with cancer needing timely germline testing for treatment decisions. Mainstreaming has emerged as an alternative approach to increase testing capacity and efficiency, where nongenetics providers perform these steps and genetics providers focus on post-test counseling for positive results. METHODS This study reports a 3-year experience with mainstreaming hereditary cancer gene panel testing at Kaiser Permanente Southern California. The study compared demographic characteristics, cancer diagnoses, and test results between patients tested by genetics providers (traditional model) versus nongenetics providers (mainstreaming) over 3 years. Over 32,000 germline hereditary cancer gene panels were completed, including nearly 12,000 mainstreaming tests. RESULTS Mainstreaming substantially increased testing volume. Patients undergoing mainstream testing were more likely to have cancer, be male, and self-report being Asian or Black. The positive test rate was slightly lower in the mainstreaming group (11%) compared with the traditional testing model (15%), with similar rates of variants of uncertain significance. Post-test genetic counseling was high in both groups for positive results. CONCLUSION This study demonstrates that mainstreaming can be successfully implemented in a large health care system and significantly expand testing capacity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingDelivery of Health Care, IntegratedGerm-Line MutationNeoplasmsGenetic Predisposition to DiseaseHumansMaleFemaleMiddle AgedAdultGenetic CounselingAged

Autor:innen und Institutionen

  • Department of Genetics, Southern California Kaiser Permanente Medical Group, Pasadena, CA.
  • Bernard J. Tyson School of Medicine, Southern California Kaiser Permanente Medical Group, Pasadena, CA.
  • Department of Hematology/Oncology, Southern California Kaiser Permanente Medical Group, Pasadena, CA.
  • Department of Gynecology-Oncology, Southern California Kaiser Permanente Medical Group, Pasadena, CA.
  • Department of Research & Evaluation, Southern California Kaiser Permanente Medical Group, Pasadena, CA.

ORCID-Profile: Trevor L Hoffman, Farah M Brasfield, John Goff, Reina Haque

Zitieren

APA

Hoffman, T. L., Brasfield, F. M., Tewari, D., Greenberg, J. D., Kershberg, H. B., Goff, J., Haque, R., & Alvarado, M. (2025). Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery System. JCO Oncology Practice. https://doi.org/10.1200/op-24-00717

Vancouver

Hoffman TL, Brasfield FM, Tewari D, Greenberg JD, Kershberg HB, Goff J, et al. Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery System. JCO Oncology Practice. 2025. doi:10.1200/op-24-00717

BibTeX
@article{Hoffman2025,
  author = {Hoffman, Trevor L and Brasfield, Farah M and Tewari, Devansu and Greenberg, Jeffery D and Kershberg, Hilary B and Goff, John and Haque, Reina and Alvarado, Monica},
  title = {Expanding Germline Hereditary Cancer Gene Panel Testing by Nongenetics Providers: 3-Year Experience in Large Integrated Health Care Delivery System},
  journal = {JCO Oncology Practice},
  year = {2025},
  doi = {10.1200/op-24-00717}
}
Kostenlos starten →